Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The American Journal of Cardiology|July 14, 2022
Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials)Rubina Attar, Angie Wu, Daniel Wojdyla, et al.International Journal of Cardiology|December 8, 2022
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney functionJosefin Mörtberg, Barbara Salzinger, Kristina Lundwall, et al.Journal of Hypertension|November 25, 2025
Systolic inter-arm blood pressure difference and subclinical atherosclerosis: a population-based cohort study of 29 921 individualsAnders Gottsäter, Ardwan Dakhel, Stefan Acosta, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 8, 2026
Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European CohortsJosefin Sundh, William A E Parker, Jonas Oldgren, et al.BMJ Open|May 9, 2025
Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional studyWilliam A E Parker, Josefin Sundh, Jonas Oldgren, et al.European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomesMaddalena Lettino, Pontus Andell, Uwe Zeymer, et al.European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.Pageof 6